BP101 for Adults With Female Sexual Dysfunction

Summary

This study is to confirm efficacy and safety of study drug BP101 in female patients with with decrease or loss of sexual desire, which is equal to acquired generalized hypoactive sexual desire disorder (HSDD). Patients will be randomized in 1:1 ratio to either BP101 or placebo arms.

Timeline

Start

2018-03-05

Primary completion

2018-11-26

Completion

2019-01-23

Drugs

Indications